Edwards Lifesciences Corporation Stock
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.83 USD | -0.20% |
|
-1.76% | -0.27% |
06-20 | Jefferies Adjusts Price Target on Edwards Lifesciences to $77 From $73 | MT |
06-16 | Edwards Lifesciences Insider Sold Shares Worth $673,268, According to a Recent SEC Filing | MT |
Capitalization | 43.31B 37.57B 35.39B 32.15B 59.48B 3,751B 67.02B 419B 160B 1,718B 163B 159B 6,317B | P/E ratio 2025 * |
30.5x | P/E ratio 2026 * | 27.4x |
---|---|---|---|---|---|
Enterprise value | 39.94B 34.65B 32.63B 29.65B 54.86B 3,459B 61.81B 386B 148B 1,585B 150B 147B 5,826B | EV / Sales 2025 * |
6.78x | EV / Sales 2026 * | 6.04x |
Free-Float |
89.32% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Edwards Lifesciences Corporation
More recommendations
More press releases
1 day | -0.20% | ||
1 week | -1.76% | ||
Current month | -5.61% | ||
1 month | -1.28% | ||
3 months | +4.78% | ||
6 months | -1.31% | ||
Current year | -0.27% |
1 week | 72.42 | ![]() | 74.75 |
1 month | 72.42 | ![]() | 78.75 |
Current year | 65.94 | ![]() | 78.75 |
1 year | 58.93 | ![]() | 95.25 |
3 years | 58.93 | ![]() | 107.92 |
5 years | 58.93 | ![]() | 131.73 |
10 years | 20.84 | ![]() | 131.73 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 2023-05-10 | |
Scott Ullem
DFI | Director of Finance/CFO | 58 | 2013-12-31 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 2019-01-31 |
Director | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 61 | 2015-02-09 |
Director/Board Member | 57 | 2023-05-10 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
2.46% | 45 M€ | -6.41% | - | |
2.34% | 21 M€ | -0.42% | - | |
1.17% | 25 M€ | -2.99% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.20% | -1.76% | -18.78% | -18.68% | 43.31B | ||
-0.03% | -0.55% | +17.75% | +153.89% | 183B | ||
+1.36% | -1.21% | -29.53% | -23.37% | 150B | ||
-0.07% | +1.56% | +30.36% | +173.56% | 150B | ||
+1.00% | -2.13% | -22.97% | -20.14% | 141B | ||
+0.72% | +1.27% | -12.81% | +3.89% | 59.43B | ||
+0.58% | -4.22% | -21.90% | -27.19% | 38.29B | ||
+1.12% | +1.74% | +23.25% | +24.98% | 37.13B | ||
+0.03% | -1.30% | -13.28% | +1.55% | 32.83B | ||
-0.85% | -1.34% | -9.97% | - | 32.64B | ||
Average | +0.37% | -0.77% | -5.79% | +29.83% | 86.68B | |
Weighted average by Cap. | +0.46% | -0.60% | -2.52% | +56.50% |
2025 * | 2026 * | |
---|---|---|
Net sales | 5.89B 5.11B 4.81B 4.37B 8.09B 510B 9.12B 57.01B 21.82B 234B 22.11B 21.64B 859B | 6.45B 5.6B 5.27B 4.79B 8.86B 559B 9.99B 62.45B 23.9B 256B 24.22B 23.7B 941B |
Net income | 1.42B 1.23B 1.16B 1.06B 1.95B 123B 2.2B 13.76B 5.27B 56.44B 5.34B 5.22B 207B | 1.58B 1.37B 1.29B 1.17B 2.17B 137B 2.44B 15.28B 5.85B 62.68B 5.93B 5.8B 230B |
Net Debt | -3.37B -2.92B -2.75B -2.5B -4.62B -292B -5.21B -32.58B -12.47B -134B -12.63B -12.36B -491B | -4.31B -3.74B -3.52B -3.2B -5.92B -373B -6.67B -41.7B -15.96B -171B -16.17B -15.83B -629B |
More financial data
* Estimated data
Employees
15,800
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-06-20 | 73.83 $ | -0.20% | 7,031,046 |
25-06-18 | 73.98 $ | +0.97% | 3,983,296 |
25-06-17 | 73.27 $ | -2.07% | 3,013,112 |
25-06-16 | 74.82 $ | -0.44% | 2,925,588 |
Delayed Quote Nyse, June 20, 2025 at 04:00 pm
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
73.83USD
Average target price
81.01USD
Spread / Average Target
+9.72%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition